The potential risk of AVM rupture was evaluated during the A Randomized demo of Unruptured Brain Arteriovenous malformations (ARUBA) demo. This study discovered a lessened possibility of stroke and mortality in sufferers managed conservatively as opposed to sufferers who underwent interventional therapy.[13]  The ARUBA trial in comparison medical management by https://www.sgvascularctr.com/service/vascular-malformations/